A second study by Griffin et al. [25] observed significantly reduced contents of GSK3β, coupled with a significantly elevated ratio of ser9-phospho-GSK3β/total GSK3β, implicating inactivation of GSK3β in AD compared to control brain specimens. The gene discussed is GSK3B; the disease is Alzheimer disease.